-
1449P Hospital volume and beyond first-line palliative systemic treatment administration in metastatic esophagogastric adenocarcinoma: A population-based study
Willemieke P.M. Dijksterhuis, Rob H.A. Verhoeven, Marieke Pape, Marije Slingerland, Nadia Haj Mohammad, Judith de Vos‐Geelen, +6 more
0citations -
1628MO A new benchmark for designing phase II trials for advanced or metastatic leiomyosarcoma (LMS) patients using progression free survival (PFS) as primary endpoint – an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis
Georgios Kantidakis, Saskia Litière, Anouk Neven, Marie Vinches, Ian Robert Judson, Patrick Schöffski, +7 more
0citations -
316P Implementation of Vela Analytics to accelerate comprehensive interpretation and reporting of next-generation sequencing-based oncology testing in clinical diagnostic laboratories2020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access
Yin Yu, O. Scully, T. Zhang, Z.H. Kyaw, V.Y. Chung, Pramila Nuwantha Ariyaratne, +4 more
0citations -
1009P Current strategies of cell and gene therapy for solid tumors: Preliminary results of the joint international ESMO and EBMT Cell Therapy and Immunobiology Working Party questionnaire-based survey
P. Comoli, George E. Pentheroudakis, Paolo Pedrazzoli, Annalisa Ruggeri, Ulrike Koehl, Florian Lordick, +6 more
0citations -
685P Genome-wide association meta-analysis identifies novel variants that correlate with efficacy outcomes in sunitinib-treated patients with metastatic renal cell carcinoma
Meta H.M. Diekstra, Jesse Joachim Swen, L. van der Zanden, Epic Boven, Ron H.J. Mathijssen, Arna Óskarsdóttir, +13 more
0citations -
1081P Hospital variation in cancer treatments and survival outcomes of advanced melanoma patients: Nation-wide quality assurance in the Netherlands
Jesper van Breeschoten, Alfons J.M. van den Eertwegh, Liesbeth C. de Wreede, Doranne L. Hilarius, Erik W. van Zwet, John B.A.G. Haanen, +14 more
0citations -
1506MO Incorporating genetic and non-genetic risk factors in breast cancer risk prediction for healthy women with non-informative genetic test result2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Anja Tüchler, Robert Remy, Julia Dick, Corinna Ernst, Britta Blümcke, Inge M. M. Lakeman, +6 more
0citations -
P-101 Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2019: A population-based study2022 Annals of Oncology conference-abstract Medicine Esophageal Cancer Research and Treatment Open access
Marieke Pape, Steven C. Kuijper, P.A. Vissers, Jelle P. H. Ruurda, Karen J. Neelis, Hanneke W.M. van Laarhoven, +1 more
0citations -
791MO Clinical and tumor characteristics of patients (pts) with recurrence after pathologic response upon neoadjuvant ipilimumab (IPI) + nivolumab (NIVO) in stage III melanoma
J.M. Versluis, Robert Elens, Irene L. M. Reijers, Alexander Maxwell Menzies, Astrid A.M. van der Veldt, E. Kapiteijn, +12 more
0citations -
860P The IOpener study: Tyrosine kinase activity in peripheral lymphocytes to predict durable response to immune checkpoint inhibition in patients with advanced melanoma
Karlijn de Joode, Karijn P.M. Suijkerbuijk, J.W.B. de Groot, Astrid A.M. van der Veldt, Hans M. Westgeest, Rik de Wijn, +12 more
0citations -
257P Efficacy of pembrolizumab in pre-treated breast cancer harboring high mutational load 140-290 – results from the Drug Rediscovery Protocol (DRUP)
Laurien Joanna Zeverijn, Birgit S. Geurts, Jade M. van Berge Henegouwen, Louisa Rose Hoes, Hanneke van der Wijngaart, G.F. de Wit, +8 more
0citations -
278P Association between tamoxifen and endoxifen plasma levels and clotting proteins in patients with primary breast cancer2023 Annals of Oncology article Medicine Venous Thromboembolism Diagnosis and Management Open access
D. van Dorst, Sanne M. Buijs, Marieke J.H.A. Kruip, Rob F. P. van den Akker, Kwok‐Leung Cheung, Robert Porrazzo, +8 more
0citations